The European Medicines Agency (EMA) will start an ongoing evaluation of the corona pill Molnupiravir next week. A Danish chief medical officer thinks the pill looks promising.
The pill could prevent the coronavirus from multiplying, and in that way, there would be fewer viruses in the body, professor at Aarhus University and chief medical officer at Aarhus University Hospital, Lars Østergaard, explained.
“This means that the risk of infection transmission is reduced and that you could thus help slow the spread of infection,” he added.
According to the manufacturer Merck, the corona pill can halve the risk of hospitalization and death.
The US authorities have previously said that they will invest more than NOK 25 billion in the development of antiviral drugs against COVID-19 and other dangerous viruses.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at firstname.lastname@example.org